Evidence map›Paper›PMID 32377194›Full record

ArticleJournal of oncology2020

Mucinous Histology,

Noa Harpaz, Yair Eli Gatt, Roy Zvi Granit, Hila Fruchtman, Ayala Hubert, Albert Grinshpun

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Risk of colon cancer-related death in people who had cancer in the past.International journal of colorectal disease · 2022
    Article
  4. PARP Inhibitor Insensitivity toJCO precision oncology · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Corrigendum to "Mucinous Histology,Journal of oncology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Noa HarpazSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Yair Eli GattDepartment of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Roy Zvi GranitSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Hila FruchtmanRadiology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Ayala HubertSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Albert GrinshpunSharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID https://orcid.org/0000-0002-3351-5719
Hadassah Medical Center · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucinous colorectal carcinomas (MC) constitute 10% of colorectal malignancies. Recently, an increased risk of colorectal cancer has been demonstrated in germline

Identifiers

PMID32377194
PMCPMC7196997
OpenAlexW3017953613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.